BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21149716)

  • 41. 4,4'-Diisothiocyanato-2,2'-Stilbenedisulfonic Acid (DIDS) Modulates the Activity of KCNQ1/KCNE1 Channels by an Interaction with the Central Pore Region.
    Bollmann E; Schreiber JA; Ritter N; Peischard S; Ho HT; Wünsch B; Strünker T; Meuth S; Budde T; Strutz-Seebohm N; Seebohm G
    Cell Physiol Biochem; 2020 Apr; 54(2):321-332. PubMed ID: 32259418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels.
    Seebohm G; Sanguinetti MC; Pusch M
    J Physiol; 2003 Oct; 552(Pt 2):369-78. PubMed ID: 14561821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KCNE4 domains required for inhibition of KCNQ1.
    Manderfield LJ; Daniels MA; Vanoye CG; George AL
    J Physiol; 2009 Jan; 587(2):303-14. PubMed ID: 19029186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sexual dimorphism and oestrogen regulation of KCNE3 expression modulates the functional properties of KCNQ1 K⁺ channels.
    Alzamora R; O'Mahony F; Bustos V; Rapetti-Mauss R; Urbach V; Cid LP; Sepúlveda FV; Harvey BJ
    J Physiol; 2011 Nov; 589(Pt 21):5091-107. PubMed ID: 21911611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis for K(V)7.1-KCNE(x) interactions in the I(Ks) channel complex.
    Lundby A; Tseng GN; Schmitt N
    Heart Rhythm; 2010 May; 7(5):708-13. PubMed ID: 20206317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Building KCNQ1/KCNE1 channel models and probing their interactions by molecular-dynamics simulations.
    Xu Y; Wang Y; Meng XY; Zhang M; Jiang M; Cui M; Tseng GN
    Biophys J; 2013 Dec; 105(11):2461-73. PubMed ID: 24314077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1.
    Lvov A; Gage SD; Berrios VM; Kobertz WR
    J Gen Physiol; 2010 Jun; 135(6):607-18. PubMed ID: 20479109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase.
    Alesutan I; Föller M; Sopjani M; Dërmaku-Sopjani M; Zelenak C; Fröhlich H; Velic A; Fraser S; Kemp BE; Seebohm G; Völkl H; Lang F
    Mol Membr Biol; 2011 Feb; 28(2):79-89. PubMed ID: 21231794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
    Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
    [No Abstract]   [Full Text] [Related]  

  • 50. KCNE1 and KCNE3 stabilize and/or slow voltage sensing S4 segment of KCNQ1 channel.
    Nakajo K; Kubo Y
    J Gen Physiol; 2007 Sep; 130(3):269-81. PubMed ID: 17698596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autonomic control of cardiac action potentials: role of potassium channel kinetics in response to sympathetic stimulation.
    Terrenoire C; Clancy CE; Cormier JW; Sampson KJ; Kass RS
    Circ Res; 2005 Mar; 96(5):e25-34. PubMed ID: 15731462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KCNE variants reveal a critical role of the beta subunit carboxyl terminus in PKA-dependent regulation of the IKs potassium channel.
    Kurokawa J; Bankston JR; Kaihara A; Chen L; Furukawa T; Kass RS
    Channels (Austin); 2009; 3(1):16-24. PubMed ID: 19077539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells.
    Dong MQ; Lau CP; Gao Z; Tseng GN; Li GR
    J Membr Biol; 2006 Apr; 210(3):183-92. PubMed ID: 16909339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1.
    Chan PJ; Osteen JD; Xiong D; Bohnen MS; Doshi D; Sampson KJ; Marx SO; Karlin A; Kass RS
    J Gen Physiol; 2012 Feb; 139(2):135-44. PubMed ID: 22250012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel.
    Chen J; Zheng R; Melman YF; McDonald TV
    PLoS One; 2009; 4(4):e5143. PubMed ID: 19340287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steric hindrance between S4 and S5 of the KCNQ1/KCNE1 channel hampers pore opening.
    Nakajo K; Kubo Y
    Nat Commun; 2014 Jun; 5():4100. PubMed ID: 24920132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of an LQT5-related mutation in KCNE1, Y81C: implications for a role of KCNE1 cytoplasmic domain in IKs channel function.
    Wu DM; Lai LP; Zhang M; Wang HL; Jiang M; Liu XS; Tseng GN
    Heart Rhythm; 2006 Sep; 3(9):1031-40. PubMed ID: 16945797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin treatment augments KCNQ1/KCNE1 currents but not KCNQ1 currents, which is associated with an increase in KCNE1 expression.
    Wu M; Obara Y; Ohshima S; Nagasawa Y; Ishii K
    Biochem Biophys Res Commun; 2017 Nov; 493(1):409-415. PubMed ID: 28882596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
    Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
    Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature.
    Unsöld B; Kerst G; Brousos H; Hübner M; Schreiber R; Nitschke R; Greger R; Bleich M
    Pflugers Arch; 2000 Dec; 441(2-3):368-78. PubMed ID: 11211125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.